Immune thrombocytopenic purpura associated with COVID‐19 Pfizer‐BioNTech BNT16B2b2 mRNA vaccine

por Krajewski, P. K., Szepietowski, J. C.
Publicado no J Eur Acad Dermatol Venereol (2021)

The New Insight into the Role of Antimicrobial Proteins-Alarmins in the Immunopathogenesis of Psoriasis

por Batycka-Baran, A., Maj, J., Wolf, R., Szepietowski, J. C.
Publicado em 2014

Identification and differentiation of Trichophyton rubrum clinical isolates using PCR-RFLP and RAPD methods

por Hryncewicz-Gwóźdź, A., Jagielski, T., Dobrowolska, A., Szepietowski, J. C., Baran, E.
Publicado em 2011

Granulocyte–macrophage colony‐stimulating factor (GM‐CSF) as a therapeutic target in psoriasis: randomized, controlled investigation using namilumab, a specific human anti‐GM‐CSF m...

por Papp, K.A., Gooderham, M., Jenkins, R., Vender, R., Szepietowski, J.C., Wagner, T., Hunt, B., Souberbielle, B.
Publicado no Br J Dermatol (2018)

Quality of life outcomes in adults with moderate‐to‐severe plaque psoriasis treated with dimethylfumarate (DMF): a post hoc analysis of the BRIDGE study

por van de Kerkhof, P.C.M., Loewe, R., Mrowietz, U., Falques, M., Pau‐Charles, I., Szepietowski, J.C.
Publicado no J Eur Acad Dermatol Venereol (2019)

Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes on quality of life issues in dermatologic pati...

por Chernyshov, P.V., Tomas‐Aragones, L., Augustin, M., Svensson, A., Bewley, A., Poot, F., Szepietowski, J.C., Marron, S.E., Manolache, L., Pustisek, N., Suru, A., Salavastru, C.M., Blome, C., Salek, M.S., Abeni, D., Sampogna, F., Dalgard, F., Linder, D., Evers, A.W.M., Finlay, A.Y.
Publicado no J Eur Acad Dermatol Venereol (2020)